United States Drugs for Vulvovaginal Candidiasis Market Report 2016

Publisher Name :
Date: 06-Oct-2016
No. of pages: 120
Inquire Before Buying

Notes:

Sales, means the sales volume of Drugs for Vulvovaginal Candidiasis

Revenue, means the sales value of Drugs for Vulvovaginal Candidiasis

This report studies sales (consumption) of Drugs for Vulvovaginal Candidiasis in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Bayer

- Janssen

- Viamet Pharmaceuticals

- Actavis

- Tianjin Kingyork Group

- Tianjin Pacific Pharmaceutical

- Cisen Pharmaceutical

- ...

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Miconazole

- Clotrimazole

- Fluconazole

Split by applications, this report focuses on sales, market share and growth rate of Drugs for Vulvovaginal Candidiasis in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Drugs for Vulvovaginal Candidiasis Market Report 2016

Table of Contents
United States Drugs for Vulvovaginal Candidiasis Market Report 2016
1 Drugs for Vulvovaginal Candidiasis Overview
1.1 Product Overview and Scope of Drugs for Vulvovaginal Candidiasis
1.2 Classification of Drugs for Vulvovaginal Candidiasis
1.2.1 Miconazole
1.2.2 Clotrimazole
1.2.3 Fluconazole
1.3 Application of Drugs for Vulvovaginal Candidiasis
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Drugs for Vulvovaginal Candidiasis (2011-2021)
1.4.1 United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2011-2021)
1.4.2 United States Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2011-2021)
2 United States Drugs for Vulvovaginal Candidiasis Competition by Manufacturers
2.1 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Drugs for Vulvovaginal Candidiasis Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Drugs for Vulvovaginal Candidiasis Average Price by Manufactures (2015 and 2016)
2.4 Drugs for Vulvovaginal Candidiasis Market Competitive Situation and Trends
2.4.1 Drugs for Vulvovaginal Candidiasis Market Concentration Rate
2.4.2 Drugs for Vulvovaginal Candidiasis Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Drugs for Vulvovaginal Candidiasis Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Type (2011-2016)
3.2 United States Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Type (2011-2016)
3.3 United States Drugs for Vulvovaginal Candidiasis Price by Type (2011-2016)
3.4 United States Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Type (2011-2016)
4 United States Drugs for Vulvovaginal Candidiasis Sales (Volume) by Application (2011-2016)
4.1 United States Drugs for Vulvovaginal Candidiasis Sales and Market Share by Application (2011-2016)
4.2 United States Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Drugs for Vulvovaginal Candidiasis Manufacturers Profiles/Analysis
5.1 Bayer
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Bayer Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Janssen
5.2.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Janssen Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Viamet Pharmaceuticals
5.3.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Viamet Pharmaceuticals Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Actavis
5.4.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Actavis Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Tianjin Kingyork Group
5.5.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Tianjin Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Tianjin Pacific Pharmaceutical
5.6.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Tianjin Pacific Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Cisen Pharmaceutical
5.7.2 Drugs for Vulvovaginal Candidiasis Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
6 Drugs for Vulvovaginal Candidiasis Manufacturing Cost Analysis
6.1 Drugs for Vulvovaginal Candidiasis Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Drugs for Vulvovaginal Candidiasis Market Forecast (2016-2021)
10.1 United States Drugs for Vulvovaginal Candidiasis Sales, Revenue Forecast (2016-2021)
10.2 United States Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2016-2021)
10.3 United States Drugs for Vulvovaginal Candidiasis Sales Forecast by Application (2016-2021)
10.4 Drugs for Vulvovaginal Candidiasis Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Drugs for Vulvovaginal Candidiasis
Table Classification of Drugs for Vulvovaginal Candidiasis
Figure United States Sales Market Share of Drugs for Vulvovaginal Candidiasis by Type in 2015
Figure Miconazole Picture
Figure Clotrimazole Picture
Figure Fluconazole Picture
Table Application of Drugs for Vulvovaginal Candidiasis
Figure United States Sales Market Share of Drugs for Vulvovaginal Candidiasis by Application in 2015
Figure United States Drugs for Vulvovaginal Candidiasis Sales and Growth Rate (2011-2021)
Figure United States Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate (2011-2021)
Table United States Drugs for Vulvovaginal Candidiasis Sales of Key Manufacturers (2015 and 2016)
Table United States Drugs for Vulvovaginal Candidiasis Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Vulvovaginal Candidiasis Sales Share by Manufacturers
Figure 2016 Drugs for Vulvovaginal Candidiasis Sales Share by Manufacturers
Table United States Drugs for Vulvovaginal Candidiasis Revenue by Manufacturers (2015 and 2016)
Table United States Drugs for Vulvovaginal Candidiasis Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Drugs for Vulvovaginal Candidiasis Revenue Share by Manufacturers
Table 2016 United States Drugs for Vulvovaginal Candidiasis Revenue Share by Manufacturers
Table United States Market Drugs for Vulvovaginal Candidiasis Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Drugs for Vulvovaginal Candidiasis Average Price of Key Manufacturers in 2015
Figure Drugs for Vulvovaginal Candidiasis Market Share of Top 3 Manufacturers
Figure Drugs for Vulvovaginal Candidiasis Market Share of Top 5 Manufacturers
Table United States Drugs for Vulvovaginal Candidiasis Sales by Type (2011-2016)
Table United States Drugs for Vulvovaginal Candidiasis Sales Share by Type (2011-2016)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Type in 2015
Table United States Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Type (2011-2016)
Table United States Drugs for Vulvovaginal Candidiasis Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drugs for Vulvovaginal Candidiasis by Type (2011-2016)
Table United States Drugs for Vulvovaginal Candidiasis Price by Type (2011-2016)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Type (2011-2016)
Table United States Drugs for Vulvovaginal Candidiasis Sales by Application (2011-2016)
Table United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2011-2016)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Market Share by Application in 2015
Table United States Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Application (2011-2016)
Figure United States Drugs for Vulvovaginal Candidiasis Sales Growth Rate by Application (2011-2016)
Table Bayer Basic Information List
Table Bayer Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Janssen Basic Information List
Table Janssen Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Viamet Pharmaceuticals Basic Information List
Table Viamet Pharmaceuticals Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Viamet Pharmaceuticals Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Actavis Basic Information List
Table Actavis Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Actavis Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Tianjin Kingyork Group Basic Information List
Table Tianjin Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tianjin Kingyork Group Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Tianjin Pacific Pharmaceutical Basic Information List
Table Tianjin Pacific Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tianjin Pacific Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Cisen Pharmaceutical Basic Information List
Table Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Vulvovaginal Candidiasis
Figure Manufacturing Process Analysis of Drugs for Vulvovaginal Candidiasis
Figure Drugs for Vulvovaginal Candidiasis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Vulvovaginal Candidiasis Major Manufacturers in 2015
Table Major Buyers of Drugs for Vulvovaginal Candidiasis
Table Distributors/Traders List
Figure United States Drugs for Vulvovaginal Candidiasis Production and Growth Rate Forecast (2016-2021)
Figure United States Drugs for Vulvovaginal Candidiasis Revenue and Growth Rate Forecast (2016-2021)
Table United States Drugs for Vulvovaginal Candidiasis Production Forecast by Type (2016-2021)
Table United States Drugs for Vulvovaginal Candidiasis Consumption Forecast by Application (2016-2021)
  • 2018-2023 Global Liquid Chromatography Detectors Consumption Market Report
    Published: 20-Aug-2018        Price: US 4660 Onwards        Pages: 131
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Liquid Chromatography Detectors market for 2018-2023. Liquid Chromatography Detectors is a device used in liquid chromatography (LC) to detect components of the mixture being eluted off the chromatography column. A broad range of detectors is available to meet different sample requirements. Specific detectors respond to a particular compound only and the re......
  • 2018-2023 Global Platelet Rich Plasma (PRP) Consumption Market Report
    Published: 20-Aug-2018        Price: US 4660 Onwards        Pages: 133
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Platelet Rich Plasma (PRP) market for 2018-2023. Platelet Rich Plasma is a biologic isolated from whole blood that is preferentially enriched for platelets. While platelets are the primary component of PRP, preparations may also contain other cellular components such as white blood cells (WBCs) and peripheral stem cells. These components all play a biologic......
  • 2018-2023 Global Pimozide Consumption Market Report
    Published: 20-Aug-2018        Price: US 4660 Onwards        Pages: 134
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Pimozide market for 2018-2023. Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for......
  • 2018-2023 Global Vitamin B12 (Cobalamin, Cyanocobalamin) Consumption Market Report
    Published: 20-Aug-2018        Price: US 4660 Onwards        Pages: 162
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Vitamin B12 (Cobalamin, Cyanocobalamin) market for 2018-2023. This report studies the Cyanocobalamin market, Cyanocobalamin is a man-made form of vitamin B12. Vitamin B12 is important for growth, cell reproduction, blood formation, and protein and tissue synthesis. Cyanocobalamin is used to treat vitamin B12 deficiency in people with pernicio......
  • 2018-2023 Global Enteral Feeding Tube Consumption Market Report
    Published: 20-Aug-2018        Price: US 4660 Onwards        Pages: 158
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Enteral Feeding Tube market for 2018-2023. Enteral feeding refers to the delivery of a nutritionally complete feed, containing protein, carbohydrate, fat, water, minerals and vitamins, directly into the stomach, duodenum or jejunum. A feeding tube is a medical device used to provide nutrition to people who cannot obtain nutrition by mouth, ar......
  • 2018-2023 Global Medicinal Mushroom Extracts Consumption Market Report
    Published: 20-Aug-2018        Price: US 4660 Onwards        Pages: 162
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Medicinal Mushroom Extracts market for 2018-2023. Medicinal mushrooms have long been recognized for their health benefits in Eastern medicine; traditional medicine has used mushrooms for thousands of years. Studies have found that these medicinal mushrooms contain a variety of components that act as antioxidants, support immune function, and even promote ce......
  • Global and India Plasminogen Market Research by Company, Type & Application 2013-2025
    Published: 19-Aug-2018        Price: US 2000 Onwards        Pages: 81
    Summary Plasminogen, the proenzyme of the fibrinolytically active enzyme plasmin, is a single chain glycoprotein with a molecular weight of about 90,000-94,000 Da (2). Various isoelectric forms exist and can be separated by means of isoelectric focusing (IEF). Market Segment as follows: By Type - Intravenous Injection - Eye drops By Application - Ligneous Conjunctivitis - Diabetic Foot - Wound Healing ......
  • Global and India Vegetable (HPMC) Capsule Market Research by Company, Type & Application 2013-2025
    Published: 19-Aug-2018        Price: US 2000 Onwards        Pages: 103
    Summary Hydroxypropyl methylcellulose is a methylcellulose modified with a small amount of propylene glycol ether groups attached to the anhydroglucose of the cellulose. HPMC Capsules are two-piece capsules made from cellulosic raw materials that satisfy vegetarian, religion, cultural and policy needs. These vegetable capsules are an attractive, all natural dosage form that retain all the advantages - easy to swallow, effectively mask taste and odor, and allow product visibility. ......
  • Global and India Prostaglandin Market Research by Company, Type & Application 2013-2025
    Published: 19-Aug-2018        Price: US 2000 Onwards        Pages: 116
    Summary Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostagla......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs